Ciaffi, J.; Festuccia, G.; Ripamonti, C.; Mancarella, L.; Brusi, V.; Pignatti, F.; Lisi, L.; Berti, L.; Ruscitti, P.; Faldini, C.;
et al. Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenous Neridronate: A Single-Center Real-Life Experience. Pharmaceuticals 2024, 17, 1500.
https://doi.org/10.3390/ph17111500
AMA Style
Ciaffi J, Festuccia G, Ripamonti C, Mancarella L, Brusi V, Pignatti F, Lisi L, Berti L, Ruscitti P, Faldini C,
et al. Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenous Neridronate: A Single-Center Real-Life Experience. Pharmaceuticals. 2024; 17(11):1500.
https://doi.org/10.3390/ph17111500
Chicago/Turabian Style
Ciaffi, Jacopo, Gianluca Festuccia, Claudio Ripamonti, Luana Mancarella, Veronica Brusi, Federica Pignatti, Lucia Lisi, Lisa Berti, Piero Ruscitti, Cesare Faldini,
and et al. 2024. "Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenous Neridronate: A Single-Center Real-Life Experience" Pharmaceuticals 17, no. 11: 1500.
https://doi.org/10.3390/ph17111500
APA Style
Ciaffi, J., Festuccia, G., Ripamonti, C., Mancarella, L., Brusi, V., Pignatti, F., Lisi, L., Berti, L., Ruscitti, P., Faldini, C., & Ursini, F.
(2024). Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenous Neridronate: A Single-Center Real-Life Experience. Pharmaceuticals, 17(11), 1500.
https://doi.org/10.3390/ph17111500
